Biochemical markers of bone turnover and bone loss at the lumbar spine and femoral neck: The Taiji study

Calcified Tissue International

Volumn 65, Issue 3, 1999, Pages 198-202

  Yoshimura, N ^a,c   Hashimoto, T ^a   Sakata, K ^a   Morioka, S ^a   Kasamatsu, T ^b   Cooper, C ^c  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b KOBE CITY COLLEGE OF NURSING   (Japan)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Bone metabolic markers; Bone mineral density; Epidemiology; Osteoporosis; Predictor

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; CALCIUM; DEOXYPYRIDINOLINE; PHOSPHATE; PROCOLLAGEN; PYRIDINOLINE;

ADULT; AGED; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MINERAL; BONE TURNOVER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FEMUR NECK; HUMAN; HUMAN CELL; HUMAN TISSUE; JAPAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL;

ADULT; AGED; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; FEMALE; FEMUR NECK; FOLLOW-UP STUDIES; HUMANS; JAPAN; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOPOROSIS;

EID: 0032801272     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002239900682     Document Type: Article

References (26)

1. Taylor AK, Lueken SA, Libanati C, Baylink DJ (1994) Biochemical markers of bone turnover for the clinical assessment of bone metabolism. Rheum Dis Clin North Am 20:589-607
2. Garnero P, Delmas PD (1996) New development in biochemical markers for osteoporosis. Calcif Tissue Int 59:s2-s9
3. Price PA, Williamson MK, Lothringer JW (1981) Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone. J Biol Chem 256:12760-12766
4. Price PA, Parthemore JG, Deftos LJ, Nishino SK (1980) New biochemical marker for bone metabolism. J Clin Invest 66: 878-883
5. Parfitt AM, Simon LS, Villaneuva AR, Krane SM (1987) Procollagen type I carboxy terminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with iliac bone formation rates and comparison with total alkaline phosphatase. J Bone Miner Res 2:427-436
6. Eriksen EF, Charles P, Melsen F, Mosekilde L, Risteli L, Risteli J (1993) Serum markers of type I collagen formation and degradation in metabolic bone disease. Correlation with bone histomorphometry. J Bone Miner Res 8:127-132
7. Risteli J, Elomaa I, Niemi S, Novamo A, Risteli L (1993) Radioimmunoassay for the pyridinoline cross-linked carboxyterminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem 39:635-640
8. Elomaa I, Virkkunen P, Risteli L, Risteli J (1992) Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma. Br J Cancer 66:337-341
9. Black D, Duncan A, Robins SP (1988) Quantitative analysis of the pyridinum crosslinks of collagen in urine using ion-paired, reversed-phase, high-performance liquid chromatography. Ann Clin Biochem 169:197-203
10. Uebelhart D, Gineyts E, Chapuy MC, Delmas PD (1990) Urinary excretion of pyridinum crosslinks. A new marker of bone resorption in metabolic bone disease. Bone Miner 8:87-96
11. Kasamatsu T, Yoshimura N, Morioka S, Sugita K, Hashimoto T (1996) A population survey on bone mineral density in a fishing village in Wakayama Prefecture (Part 1). Distribution of bone mineral density by sex and age on a representative sample of the community (in Japanese). Jpn J Hyg 50:1084-1092
12. Yoshimura N, Kasamatsu T, Morioka S, Hashimoto T (1996) A population survey on bone mineral density in a fishing village in Wakayama Prefecture (Part 2). Analysis of the risk factors affecting the bone mineral density. Jpn J Hyg 51:677-684
13. Yoshimura N, Hashimoto T, Morioka S, Sakata S, Kasamatsu T, Cooper C (1998) Determinants of bone loss in a rural Japanese community: the Taiji Study. Osteoporosis Int (in press)
14. Kawaguchi H, Matsumoto T, Kurokawa T, Orimo H, Mizunashi K, Takuwa Y, Niimi K, Shiraki M, Ohara T, Shiba Y, Tsuchiya Y, Takahashi E, Takatsuki K, Seino Y, Morii H, Fujita T, Okamoto S, Ogata E (1990) Serum levels of BGP determined by two-site immunoradiometric assay (IRMA) using monoclonal antibodies (in Japanese). Clin Endocrinol 38: 95-100
15. Melkko J, Niemi S, Risteli L, Risteli J (1990) Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem 36:1328-1332
16. Fujimoto D, Suzuki M, Uchiyama A, Miyamoto S, Inoue T (1983) Analysis of pyridinoline, a crosslinking compound of collagen fibers, in human urine. J Biochem 94:1133-1136
17. Yoshimura N, Kakimoto T, Nishioka M, Kishi T, Iwasaki H, Niwa T, Morioka S, Sakata T, Hashimoto T (1997) Evaluation of reproducibility of bone mineral density measured by dual energy X-ray absorptiometry (DPX-L). J Wakayama Med Soc 48:461-466
18. Arnaud CD (1996) Osteoporosis: using 'bone markers' for diagnosis and monitoring. Geriatrics 51:24-30
19. Demers LM (1997) Clinical usefulness of markers of bone degradation and formation. Scand J Clin Invest 57:s12-s20
20. Garnero P, Shih WJ, Gineyts E, Karpf DB, Delmas PD (1994) Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 79:1693-1700
21. Schlemmer A, Hassager C, Delmas PD, Christiansen C (1994) Urinary excretion of pyridinium cross-links in healthy women: the long-term effects of menopause and oestrogen/ progesterone therapy. Clin Endocrinol 40:777-782
22. Wishart JM, Need AG, Horowitz M, Morris HA, Nordin BEC (1995) Effect of age on bone density and bone turnover in men. Clin Endocrinol 42:141-146
23. Delmas PD, Stenner D, Wahner HW, Mann KG, Riggs BL (1973) Bone Gla protein increases with aging in normal women: implications for the mechanism of age-related bone loss. J Clin Invest 71:1316-1321
24. Yoshimura N, Hashimoto T, Kasamatsu T, Morioka S, Aoki N, Shiraki M (1996) Bone metabolic marker levels in residents of a rural community in Japan. J Bone Miner Metab 14:39-42
25. Slemenda C, Hui SL, Longscope C, Johnston CC (1987) Sex steroids and bone mass: a study of changes about the time of menopause. J Clin Invest 80:1261-1269
26. Johansen JR, Riis BJ, Delmas PD, Christiansen C (1988) Plasma BGP: an indicator of spontaneous bone loss and effect of oestrogen treatment in postmenopausal women. Eur J Clin Invest 18:191-195